Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2026-06-14 @ 8:01 PM
Study NCT ID:
NCT01138605
Status:
COMPLETED
Last Update Posted:
2019-05-01
First Post:
2010-04-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TMC114-TiDP29-C232 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir (Rtv) for Children Coming From Any of the Three Ongoing Tibotec Sponsored Pediatric Studies With DRV
Sponsor:
Janssen Sciences Ireland UC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CR016768
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None